Cite
HARVARD Citation
Emery, P. et al. (2020). Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study. Annals of the rheumatic diseases. 79 (8), pp. 1023-1030. [Online].